X-linked lymphoproliferative disease: Twenty-five years after the discovery

Pediatric Research

Volumn 38, Issue 4, 1995, Pages 471-478

  Seemayer, Thomas A ^a   Gross, Thomas G ^a   Egeler, R Maarten ^b   Pirruccello, Samuel J ^a   Davis, Jack R ^a   Kelly, Christopher M ^a   Okano, Motohiko ^c   Lanyi, Arpad ^a   Sumegi, Janos ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VIRUS; EPSTEIN BARR VIRUS; HETEROZYGOTE; HUMAN; HYPOTHESIS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LYMPHOPROLIFERATIVE DISEASE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SURVIVAL; VIRUS DETECTION; X CHROMOSOME; X CHROMOSOME LINKAGE;

CHILD; CHROMOSOME MAPPING; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HETEROZYGOTE DETECTION; HISTORY OF MEDICINE, 20TH CENT.; HUMAN; LINKAGE (GENETICS); LYMPHOPROLIFERATIVE DISORDERS; MALE; PHENOTYPE; PROGNOSIS; REGISTRIES; SUPPORT, NON-U.S. GOV'T; TUMOR VIRUS INFECTIONS; X CHROMOSOME;

EID: 0029161779     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/00006450-199510000-00001     Document Type: Article

References (67)

1. Burkitt D 1958 A sarcoma involving the jaws in African children. Br J Surg 46:218-223
2. O’Conor GT 1961 Malignant lymphoma in African children. II. A pathological entity. Cancer 14:270-283
3. Epstein MA, Barr YM 1964 Cultivation in vitro of human lymphoblasts from Burkitt’s malignant lymphoma. Lancet 1:252-253
4. Epstein MA, Achong BG, Barr YM 1964 Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1:702-703
5. Henle W, Diehl V, Kohn G, zur Hausen H, Henle G 1967 Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science 157:1064-1065
6. Pope JH 1967 Establishment of cell lines from peripheral leucocytes in infectious mononucleosis. Nature 216:810-811
7. Henle G, Henle W, Diehl V 1968 Relation of Burkitt’s tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci USA 59:94-101
8. Niederman JC, McCollum RW, Henle G, Henle W 1968 Infectious mononucleosis: Clinical manifestations in relation to EB virus antibodies. JAMA 203:205-209
9. Jondal M, Klein G, Oldstone MBA, Bokish V, Yefenof E 1976 Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells. Scand J Immunol 5:401-410
10. Falk L, Wolfe L, Deinhardt F, Paciga J, Dombros L, Klein G, Henle W, Henle G 1974 Epstein-Barr virus: Transformation of nonhuman primate lymphocytes in vitro. Int J Cancer 13:363-376
11. Frank A, Andiman WA, Miller G 1976 Epstein-Barr virus and nonhuman primates: Natural and experimental infection. Adv Cancer Res 23:171-201
12. Miller G, Shope T, Coope D, Waters L, Pagano J, Bornkamm GW, Henle W 1977 Lymphoma in cotton-topped marmosets after inoculation with Epstein-Barr virus: tumor incidence, histologic spectrum, antibody responses, demonstration of viral DNA, and characterization of viruses. J Exp Med 145:948-967
13. Henle W, Henle H, Ho H-C, Burtin P, Cachin Y, Clifford P, de Schryver A, de-The G, Diehl V, Klein G 1970 Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms and control groups. J Natl Cancer Inst 44:225-231
14. zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santesson L1970 EBV DNA in biopsies of Burkitt’s tumors and anaplastic carcinoma of the nasopharynx. Nature 228:1056-1058
15. Gatti RA, Good RA 1971 Occurrence of malignancy in immunodeficiency diseases: a literature review. Cancer 28:89-98
16. Penn I, Hammond W, Brettschneider L, Starzl TE 1969 Malignant lymphomas in transplantation patients. Transplant Proc 1:106-112
17. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Purtilo DT, Klein G, Simmons RL, Najarian JS 1981 The Epstein-Barr virus (EBV) in the pathogenesis of post-transplant lymphoma. Surgery 90:204-213
18. Shearer WT, Ritz J, Finegold M, Guerra IC, Rosenblatt HM, Lewis DE, Pollack MS, Taber LH, Sumaya CV, Grumet FC, Cleary ML, Warnke R, Sklar J 1985 Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. N Engl J Med 312:1151-1159
19. Okano N, Thiele GM, Davis JR, Grierson H, Purtilo DT 1988 Epstein-Barr virus and human diseases: recent advances in diagnosis. Clin Microbiol Rev 1:300-312
20. Purtilo DT, Strobaugh RS, Okano M, Davis JR 1992 Biology of disease: Epstein-Barr virus-associated lymphoproliferative disorders. Lab Invest 67:5-23
21. Borisch-Chappuis B, Miiller H, Stutle J, Hey MM, Hiibner K, Muller-Hermelink HK 1990 Identification of EBV-DNA in lymph nodes from patients with lymphadenop-athy and lymphomas associated with AIDS. Virchows Arch B Cell Pathol 58:199-205
22. Purtilo DT, Cassel CK, Yang JPS, Harper P, Stephenson SR, Landing BH, Vawter GF 1975 X-linked recessive progressive combined variable immunodeficiency (Duncan’s disease). Lancet 1:935-941
23. Hamilton JK, Paquin LA, Sullivan JL, Maurer HS, Cruzi PG, Provisor AJ, Steuber CP, Hawkins E, Yawn D, Cornet J, Clausen K, Finkelstein GZ, Landing B, Grunnet M, Purtilo DT 1980 X-linked lymphoproliferative syndrome registry report. J Pediatr 96:669-673
24. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS 1984 Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 310:1225-1230
25. Miller G, Niederman JC, Andrews L-L 1973 Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis. N Engl J Med 288:229-232
26. Gerber P, Purcell RH, Rosenblum EN, Walsh JH 1969 Association of EB-virus infection with the post-perfusion syndrome. Lancet 1:593-596
27. Liebowitz D 1995 Epstein-Barr virus: an old dog with new tricks. N Engl J Med 332:55-57
28. Purtilo DT, Grierson HL 1989 Epstein-Barr virus-induced immune deficiency. In: Specter S, Bendinelli M, Friedman H (eds) Virus-Induced Immunosuppression. Plenum Publishing, New York, pp 125-140
29. Purtilo DT, Grierson HL, Davis JR, Okano M 1991 The X-linked lymphoproliferative disease: From autopsy toward cloning the gene, 1975-1990. Pediatr Pathol 11:685-710
30. Seemayer TA, Grierson H, Pirruccello SJ, Gross TG, Weisenberger DD, Davis J, Spiegel K, Brichacek B, Sumegi J 1993 X-linked lymphoproliferative disease. Am J Dis Child 147:1242-1245
31. Mroczek EC, Seemayer TA, Grierson HL, Markin R, Linder J, Brichacek B, Purtilo DT 1987 Thymic lesions in fatal infectious mononucleosis. Clin Immunol Immuno-pathol 43:243-255
32. Seemayer TA, Bolande RP 1980 Thymic involution mimicking thymic dysplasia, a consequence of transfusion-induced graft-versHS-host disease in a premature infant. Arch Pathol Lab Med 104:141-144
33. Seemayer TA, Lapp WS, Bolande RP 1977 Thymic involution in murine graft-versus-host reaction: Epithelial injury mimicking human dysplasia. Am J Pathol 88:119-134
34. Seemayer TA, Laroche AC, Russo P, Malebranche R, Arnoux E, Guerin JM, Pierre G, Dupuy JM, Gartner JG, Lapp WS, Spira TA, Elie R 1984 Precocious thymic involution manifest by epithelial injury in the acquired immune deficiency syndrome. Hum Pathol 15:469-474
35. Egeler RM, de Kraker J, Slater R, Purtilo DT 1992 Documentation of Burkitt’s lymphoma with t(8;14)(q24;q23) in X-linked lymphoproliferative disease. Cancer 70:683-687
36. Williams LL, Rooney CM, Conley ME, Brenner MK, Krance RA, Heslop HE 1993 Correction of Duncan’s syndrome by allogeneic bone marrow transplantation. Lancet 2:587-588
37. Baranski B, Armstrong G, Truman JT, Quinnan GV Jr, Straus SE, Young NS 1989 Epstein-Barr virus in the bone marrow of patients with aplastic anemia. Ann Intern Med 109:695-704
38. Ochs HD, Sullivan JL, Wedgwood RJ, Seeley JK, Sakamoto K, Purtilo DT 1983 X-linked lymphoproliferative syndrome: abnormal antibody responses to bacteriophage φX174. Birth Defects 19:321-323
39. Gross TG, Patton DF, Davis JR, Sumegi J, Pirruccello SJ, Kelly CM and Seemayer TA 1994 X-linked lymphoproliferative disease (XLP) manifested without apparent EBV infection (abstract). The VII International Conference on the Epstein-Barr Virus and Associated Diseases, Cold Spring Harbor, NY
40. Purtilo DT, Grierson HL 1991 Methods of detection of new families with X-linked lymphoproliferative disease. Cancer Genet Cytogenet 51:143-153
41. Pracher E, Panzer-Griimayer ER, Zoubek A, Peters C, Gadner H 1994 Successful bone marrow transplantation in a boy with X-linked lymphoproliferative syndrome and acute severe infectious mononucleosis. Bone Marrow Transplant 13:655-658
42. Vowels MR, Lam-Po-Tang R, Berdoukas V, Ford D, Thierry D, Purtilo D, Gluckman E 1993 Brief report: Correction of X-linked lymphoproliferative disease by transplantation of cord-blood stem cells. N Engl J Med 329:1623-1625
43. Purtilo DT, Sullivan JL 1979 Immunological bases for superior survival in females. Am J Dis Child 133:1251-1253
44. Royer-Pokora B, Kunkel LM, Monaco AP, Goff SC, Newburger PE, Baehner RL, Cole FS, Curnutte JT, Orkin SH 1986 Cloning the gene for an inherited human disorder chronic granulomatous disease on the basis of its chromosomal location. Nature 322:32-38
45. Vetrie D, Vorechovsky I, Sideras P, Holland J, Davies A, Flinter F, Hammarstrom L, Kinnon C, Levinsky R, Bobrow M, Smith CIE, Bentley DR 1993 The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361:226-233
46. Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA 1993 Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361:539-543
47. Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, Leonard WJ 1993 Interleukin-2 receptor y chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73:147-157
48. Remold-O’Donnell E, Rosen FS 1990 Sialopharin (CD43) and the Wiskott-Aldrich syndrome. Immunodef Rev 2:151-174
49. Derry JMJ, Ochs HD, Francke U 1994 Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78:635-644
50. Skare J, Milunsky A, Byron KS, Sullivan J 1987 Mapping the X-linked lymphoproliferative syndrome. Proc Nat Acad Sci USA 84:2015-2018
51. Skare J, Sullivan J, Milunsky A 1989 Mapping the mutation causing the X-linked lymphoproliferative syndrome in relation to restriction fragment length polymorphisms on Xq. Hum Genet 82:349-353
52. Skare J, Grierson H, Sullivan J, Nussbaum RL, Purtilo DT, Sylla B, Lenoir G, Reilly DS, White BN, Milunsky A 1989 Linkage analysis of seven kindreds with the X-linked lymphoproliferative syndrome (XLP) confirms that the XLP locus is near DXS42 and DXS37. Hum Genet 82:354-358
53. Wyandt H, Grierson H, Sanger W, Skare J, Milunsky A, Purtilo DT 1989 Chromosome deletion of Xq25 in an individual with X-linked lymphoproliferative disease. Am J Med Genet 33:426-430
54. Sanger W, Grierson H, Skare J, Wyandt H, Pirruccello S, Fordyce R, Purtilo DT 1990 Partial Xq25 deletion in a family with the X-linked lymphoproliferative disease (XLP). Cancer Genet Cytogenet 47:163-169
55. Skare J, Wu B-L, Madan S, Pulijaal V, Purtilo DT, Haber D, Nelson D, Sylla B, Grierson H, Nitowsky H 1993 Characterization of three overlapping deletions causing X-linked lymphoproliferative disease. Genomics 16:254-255
56. Wu B-L, Milunsky A, Nelson D, Schmeekpeper B, Porta G, Schlessinger D, Skare J 1993 High-resolution mapping of probes near the X-linked lymphoproliferative disease (XLP) locus. Genomics 17:163-170
57. Mosmann TR, Cherwinski H, Bond MW, Ciedlin MA, Coffman RL 1986 Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348-2357
58. Scott P 1993 Selective differentiation of CD4+ T helper cell subsets. Curr Opinion Immunol 5:391-397
59. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL 1991 Defining protective responses to pathogens: Cytokine profiles in leprosy lesions. Science 254:277-279
60. Modlin RL, Nutman TB 1993 Type 2 cytokines and negative immune regulation in human infections. Curr Opinion Immunol 5:511-517
61. Bloom WH, Wallis RS, Chervenak KA 1991 Human mycobacterium tuberculosis-reactive CD4+ T-cell clones: heterogeneity in antigen recognition, cytokine production and cytotoxicity for mononuclear phagocytes. Infect Immun 59:2737-2743
62. Barns PF, Abrams JS, Lu SZ, Seiling PA, Rea TH, Modlin RL 1993 Patterns of cytokine production by mycobacterium-reactive human T-cell clones. Infect Immun 61:197-203
63. Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceicao-Silva F, Modlin RL 1991 Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 91:1390-1395
64. Mahanty S, Abrams JS, King CL, Limaye AP, Nutman TB 1992 Parallel regulation of IL-4 and IL-5 in human helminth infections. J Immunol 148:3567-3571
65. Svedmyr E, Ernberg I, Seeley J, Weiland O, Masucci G, Tsukuda K, Szigeti R, Masucci MG, Blomgren H, Berthold W, Henle W, Klein G 1984 Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis. Clin Immunol Immunopathol 30:437-450
66. Okano M, Thiele GM, Purtilo DT 1993 Variable presence of circulating cytokines in patients with sporadic or X-linked lymphoproliferative disease with fatal infectious mononucleosis. Pediatr Hematol Oncol 10:97-99
67. Purtilo DT 1991 X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology. Springer Semin Immunopathol 3:181-197